A Comparison of Direct and Indirect Methods for the Estimation of Health Utilities from Clinical Outcomes

Background: Analysts frequently estimate health state utility values from other outcomes. Utility values like EQ-5D have characteristics that make standard statistical methods inappropriate. We have developed a bespoke, mixture model approach to directly estimate EQ-5D. An indirect method, “response mapping,” first estimates the level on each of the 5 dimensions of the EQ-5D and then calculates the expected tariff score. These methods have never previously been compared. Methods: We use a large observational database from patients with rheumatoid arthritis (N = 100,398). Direct estimation of UK EQ-5D scores as a function of the Health Assessment Questionnaire (HAQ), pain, and age was performed with a limited dependent variable mixture model. Indirect modeling was undertaken with a set of generalized ordered probit models with expected tariff scores calculated mathematically. Linear regression was reported for comparison purposes. Impact on cost-effectiveness was demonstrated with an existing model. Results: The linear model fits poorly, particularly at the extremes of the distribution. The bespoke mixture model and the indirect approaches improve fit over the entire range of EQ-5D. Mean average error is 10% and 5% lower compared with the linear model, respectively. Root mean squared error is 3% and 2% lower. The mixture model demonstrates superior performance to the indirect method across almost the entire range of pain and HAQ. These lead to differences in cost-effectiveness of up to 20%. Conclusions: There are limited data from patients in the most severe HAQ health states. Modeling of EQ-5D from clinical measures is best performed directly using the bespoke mixture model. This substantially outperforms the indirect method in this example. Linear models are inappropriate, suffer from systematic bias, and generate values outside the feasible range.

[1]  J. Tobin Estimation of Relationships for Limited Dependent Variables , 1958 .

[2]  J. Raftery,et al.  Mapping the Oxford hip score onto the EQ-5D utility index , 2013, Quality of Life Research.

[3]  Helen Dakin,et al.  Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score , 2012, Quality of Life Research.

[4]  William L. Goffe,et al.  SIMANN: FORTRAN module to perform Global Optimization of Statistical Functions with Simulated Annealing , 1992 .

[5]  Sandro Ridella,et al.  Minimizing multimodal functions of continuous variables with the “simulated annealing” algorithmCorrigenda for this article is available here , 1987, TOMS.

[6]  Allan Wailoo,et al.  The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis , 2013, Rheumatology.

[7]  Geoffrey J. McLachlan,et al.  Finite Mixture Models , 2019, Annual Review of Statistics and Its Application.

[8]  Oliver Rivero-Arias,et al.  Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  A. Brennan,et al.  The Sheffield rheumatoid arthritis health economic model. , 2011, Rheumatology.

[10]  F. Wolfe,et al.  The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. , 2011, Rheumatology.

[11]  Roberta Ara,et al.  Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[13]  Aki Tsuchiya,et al.  A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures , 2010, The European Journal of Health Economics.

[14]  P. Schmidt,et al.  Limited-Dependent and Qualitative Variables in Econometrics. , 1984 .

[15]  P Barton,et al.  A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. , 2006, Health technology assessment.

[16]  Stephen Joel Coons,et al.  US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.

[17]  Oliver Rivero-Arias,et al.  Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  Alan Brennan,et al.  Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis. , 2008, Arthritis and rheumatism.

[19]  G. Maddala Limited-dependent and qualitative variables in econometrics: Introduction , 1983 .